Daniel E. Kolker

Array ( [id] => 4859136 [patent_doc_number] => 20080267986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Therapeutic vaccine' [patent_app_type] => utility [patent_app_number] => 11/637607 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31042 [patent_no_of_claims] => 110 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267986.pdf [firstpage_image] =>[orig_patent_app_number] => 11637607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7692135 [patent_doc_number] => 20070231898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury' [patent_app_type] => utility [patent_app_number] => 11/637632 [patent_app_country] => US [patent_app_date] => 2006-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16425 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11637632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5492066 [patent_doc_number] => 20090293137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Novel Gene Disruptions, Compositions and Methods Relating Thereto' [patent_app_type] => utility [patent_app_number] => 11/814413 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 102 [patent_no_of_words] => 209633 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20090293137.pdf [firstpage_image] =>[orig_patent_app_number] => 11814413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514180 [patent_doc_number] => 20090214486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Serum Response Factor and Myocardin Control Alzheimer Cerebral Amyloid Angiopathy' [patent_app_type] => utility [patent_app_number] => 12/084774 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8637 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214486.pdf [firstpage_image] =>[orig_patent_app_number] => 12084774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189056 [patent_doc_number] => 20070167365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Compositions and methods for modulating blood-brain barrier transport' [patent_app_type] => utility [patent_app_number] => 11/580497 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 32497 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167365.pdf [firstpage_image] =>[orig_patent_app_number] => 11580497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496327 [patent_doc_number] => 20090264355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'METHODS TO TREAT ALZHEIMER\'S DISEASE OR OTHER DISORDERS MEDIATED BY AMYLOID-BETA ACCUMULATION IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 12/089791 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8006 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264355.pdf [firstpage_image] =>[orig_patent_app_number] => 12089791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23841 [patent_doc_number] => 07795213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Methods of contacting β amyloid protein with VEGF' [patent_app_type] => utility [patent_app_number] => 11/548397 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 21588 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795213.pdf [firstpage_image] =>[orig_patent_app_number] => 11548397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9350460 [patent_doc_number] => 08669351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-11 [patent_title] => 'Antibodies to polypeptides encoded by aspartoacylase polynucleotides' [patent_app_type] => utility [patent_app_number] => 11/541665 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 13366 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11541665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959671 [patent_doc_number] => 20080274096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Fusion Proteins Having a Modulated Half-Life in Plasma' [patent_app_type] => utility [patent_app_number] => 12/089127 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21015 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274096.pdf [firstpage_image] =>[orig_patent_app_number] => 12089127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446074 [patent_doc_number] => 20090047300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/088337 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18082 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047300.pdf [firstpage_image] =>[orig_patent_app_number] => 12088337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533569 [patent_doc_number] => 20090233357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Targeted Delivery of Compounds Using Multimerization Technology' [patent_app_type] => utility [patent_app_number] => 11/992656 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9766 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233357.pdf [firstpage_image] =>[orig_patent_app_number] => 11992656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392559 [patent_doc_number] => 20090209872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Method and Device for Determining Flow in a Blood Vessel' [patent_app_type] => utility [patent_app_number] => 11/991982 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3485 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209872.pdf [firstpage_image] =>[orig_patent_app_number] => 11991982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148261 [patent_doc_number] => 20070048320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Method for indentifying modulators of PPIL2 useful for treating Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/514737 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11319 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048320.pdf [firstpage_image] =>[orig_patent_app_number] => 11514737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92211 [patent_doc_number] => 07732407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Method for treatment of demyelinating central nervous system disease' [patent_app_type] => utility [patent_app_number] => 11/467088 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3830 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732407.pdf [firstpage_image] =>[orig_patent_app_number] => 11467088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6525600 [patent_doc_number] => 20100203505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Msx1/2' [patent_app_type] => utility [patent_app_number] => 12/064019 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16417 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203505.pdf [firstpage_image] =>[orig_patent_app_number] => 12064019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122397 [patent_doc_number] => 07704695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Screening of compounds for BGT1 transporter activity' [patent_app_type] => utility [patent_app_number] => 11/493362 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16246 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704695.pdf [firstpage_image] =>[orig_patent_app_number] => 11493362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162084 [patent_doc_number] => 07670782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Screening of compounds for CAT1 transporter activity' [patent_app_type] => utility [patent_app_number] => 11/493363 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16604 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/670/07670782.pdf [firstpage_image] =>[orig_patent_app_number] => 11493363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141637 [patent_doc_number] => 07691584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Screening of compounds for OCT3 transporter activity' [patent_app_type] => utility [patent_app_number] => 11/493351 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16172 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691584.pdf [firstpage_image] =>[orig_patent_app_number] => 11493351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4982392 [patent_doc_number] => 20070086950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'GAT2 transporters expressed in blood brain barrier cells' [patent_app_type] => utility [patent_app_number] => 11/493372 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16085 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20070086950.pdf [firstpage_image] =>[orig_patent_app_number] => 11493372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122400 [patent_doc_number] => 07704696 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Screening of compounds for OCTN2 transporter activity' [patent_app_type] => utility [patent_app_number] => 11/493371 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16221 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704696.pdf [firstpage_image] =>[orig_patent_app_number] => 11493371 [rel_patent_id] =>[rel_patent_doc_number] =>)